✦ LIBER ✦

Durable responses in chronic myeloid leukemia patients maintained with lower doses of imatinib mesylate after achieving molecular remission

✍ Scribed by Angelo Michele Carella; Enrica Lerma

Book ID: 105988974
Publisher: Springer
Year: 2007
Tongue: English
Weight: 88 KB
Volume: 86
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-007-0326-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Imatinib dose escalation to achieve mole

Imatinib dose escalation to achieve molecular responses in patients with chronic myeloid leukemia in late chronic phase

✍ F. Stagno; P. Vigneri; V. Del Fabro; S. Stella; M. Massimino; S. Berretta; A. Me 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Durability of molecular remission in chr

Durability of molecular remission in chronic myeloid leukemia patients treated with imatinib vs allogeneic stem cell transplantation

✍ Lange, T; Bumm, T; Mueller, M; Otto, S; Al-Ali, H-K; Grommisch, L; Musiol, S; Fr 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB

Molecular responses of late chronic phas

Molecular responses of late chronic phase chronic myeloid leukemia patients after achieving complete cytogenetic responses with imatinib treatment: a 6-year follow-up

✍ YaZhen Qin; Bin Jiang; Qian Jiang; Hao Jiang; JinLan Li; Yan Zhang; HongHu Zhu; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 117 KB

Chronic myelogenous leukemia in T cell l

Chronic myelogenous leukemia in T cell lymphoid blastic phase achieving durable complete cytogenetic and molecular remission with imatinib mesylate (STI571; Gleevec) therapy

✍ Ehab Atallah; Moshe Talpaz; Susan O'brien; Mary Beth Rios; Jie Qiang Guo; Ralph 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

## Abstract ## BACKGROUND A T cell lymphoid blastic phase of chronic myelogenous leukemia (CML) is a rare occurrence, with only a few reported cases worldwide. Standard therapy for such patients is undetermined. Imatinib mesylate, a Bcr‐Abl tyrosine kinase inhibitor, has shown activity in CML. ##

Peripheral blood progenitor cell collect

Peripheral blood progenitor cell collection in chronic myeloid leukemia patients with complete cytogenetic response after treatment with imatinib mesylate

✍ Paolo Perseghin; Carlo Gambacorti-Passerini; Lucia Tornaghi; Maria Dassi; Pietro 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Sudden blast crisis in patients with Phi

Sudden blast crisis in patients with Philadelphia chromosome-positive chronic myeloid leukemia who achieved complete cytogenetic remission after imatinib therapy

✍ Giuliana Alimena; Massimo Breccia; Roberto Latagliata; Ida Carmosino; Eleonora R 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views